SCPHARMACEUTICALS INC. Accounts Payable
SCPHARMACEUTICALS INC. had Accounts Payable of $4.03 million as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-08-07
- 2025-06-30: Accounts Payable, Current $4.03M.
- 2025-03-31: Accounts Payable, Current $4.99M.
- 2024-12-31: Accounts Payable, Current $3.88M.
- 2024-09-30: Accounts Payable, Current $5.00M.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-06-30 | $4.03M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.99M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $3.88M 10-Q · filed 2025-08-07 |
| 2024-09-30 | $5.00M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $5.29M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.71M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.00M 10-K · filed 2025-03-19 |
| 2023-09-30 | $3.37M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.18M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.63M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.52M 10-K · filed 2024-03-13 |
| 2022-09-30 | $996.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $982.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $445.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $544.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $447.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $531.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $753.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.67M 10-K · filed 2022-03-22 |
| 2020-09-30 | $839.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $770.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $652.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $1.14M 10-K · filed 2021-03-23 |
| 2019-09-30 | $542.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.42M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $221.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $587.00K 10-K · filed 2020-03-24 |
| 2018-09-30 | $1.67M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.36M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.52M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $1.59M 10-K · filed 2019-03-21 |